Biotech Visionary G. Steven Burrill Offers Predictions for 2013

December 20, 2012

› Learn more

Large Venture Financings in November Point to Shift among Investors

December 04, 2012

› Learn more

Burrill & Company Continues Global Expansion with Opening of Moscow Office

November 14, 2012

› Learn more

Burrill & Company Strengthens Investment Banking Team to Expand Services for Leading Life Sciences Companies

November 05, 2012

› Learn more

Public Equity Life Sciences Financings Show Strength in October, says Burrill & Company

November 01, 2012

› Learn more

Personalized Medicine’s Transformation of Healthcare Accelerates

October 01, 2012

› Learn more

Recent Therapeutics IPOs Outperform Market, But Life Sciences Offerings a Mixed Bag, Burrill & Company Reports

September 04, 2012

› Learn more

Burrill & Company Announces Second Close of Burrill Capital Fund IV, L.P.

August 02, 2012

› Learn more

Burrill & Company Launches Investment Research with Addition of Respected Team of Analysts

August 01, 2012

› Learn more

Pharma Partnering Dollars Continue to Decline for Biotech, Burrill & Company Reports

August 01, 2012

› Learn more

Digital Health Takes Hold with Venture Investors, says Burrill & Company

July 02, 2012

› Learn more

U.S. Supreme Court Upholds Healthcare Reform

Individual Mandate Ruled Constitutional as a Tax

June 28, 2012

› Learn more

Burrill & Company Names David Wetherell, President and COO of Burrill’s Healthcare Venture

June 26, 2012

› Learn more

Burrill & Company and Khosla Ventures Lead $10.5 Million Round in AliveCor

June 11, 2012

› Learn more

Pharmaceutical Companies’ Partnering Activity with Academia, Non-Profits, Governments Picks up in May

June 01, 2012

› Learn more

Biopharmaceutical Companies that Attract Corporate Venture Investment More Likely to Be Acquired, Go Public, Analysis Finds

May 22, 2012

› Learn more

Life Sciences M&A Values Soar in 2011

May 14, 2012

› Learn more

Life Sciences M&A Activity Heats Up in April, says Burrill & Company

May 01, 2012

› Learn more

Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health

April 16, 2012

› Learn more

Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough

April 16, 2012

› Learn more

Burrill & Company Leads ADMA Biologics’ $17.5 Million Private Placement

April 15, 2012

› Learn more

Chemical Heritage Foundation Honors Biotech Visionary G. Steven Burrill

April 12, 2012

› Learn more

Government, Academics, and VCs Come Together to Fund Translational and Early-Stage Development

March 30, 2012

› Learn more

Shire to acquire Burill Portfolio Company FerroKin BioSciences

March 15, 2012

› Learn more

Improving Market Drives Life Sciences Financings in February

February 29, 2012

› Learn more

Burrill & Company Expands into Taiwan

February 24, 2012

› Learn more

Burrill & Company Advises Aldagen, Inc. in Sale of its Next Generation Cell Therapy to Cytomedix, Inc.

February 21, 2012

› Learn more

Biotech Dealmaking Gets off to a Strong Start in 2012

February 01, 2012

› Learn more

Burrill & Company Announces Close of Burrill Brazil Fund I

January 18, 2012

› Learn more

David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director

January 06, 2012

› Learn more

Burrill & Company’s Merchant Banking Group Launches Institutional Equities Research Division with Addition of Jason Zhang, Ph.D., as Senior Research Analyst

January 06, 2012

› Learn more

Global Financial Market Turmoil Overshadows Biotech Successes in 2011

January 03, 2012

› Learn more